Catherine Dargan has been advising clients on M&A transactions for more than 20 years, working on deals in a range of industries, with particular expertise in life sciences.

“There’s been a lot of disposing of non-core assets,” Dargan says. “Companies have been rationalizing their portfolios.” Dargan adds that several companies have been focusing less on initial public offerings and more on M&A.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.